Exploiting alloreactivity for tumour immunotherapy.
Stauss
H J
HJ
Imperial College London, UK. h.stauss@imperial.ac.uk
Xue
S
S
Gillmore
R
R
Gao
L
L
Bendle
G
G
Holler
A
A
Downs
A-M
AM
Morris
E
E
D006086:Graft vs Host Disease / Q000276:immunology; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D009369:Neoplasms / Q000628:therapy*; D011948:Receptors, Antigen, T-Cell / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D011948:Receptors, Antigen, T-Cell